Intra-Cellular Therapies News

Intra-Cellular Therapies | DEFA14A: Others

Apr 30 04:52

Intra-Cellular Therapies | DEF 14A: Definitive information statements

Apr 30 04:14

Intra-Cellular Therapies | 8-K: Current report

Apr 25 04:24

Intra-Cellular Therapies | 8-K: Current report

Apr 19 05:28

Intra-Cellular Therapies | 8-K: Current report

Apr 17 04:46

Intra-Cellular Therapies | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Apr 17 04:07

Intra-Cellular Therapies | 8-K: Current report

Apr 16 19:14

Intra-Cellular Therapies | 8-K: Current report

Apr 2 05:20

Intra-Cellular Therapies | 8-K: Current report

Mar 19 20:46

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Feb 22 20:41

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND RAISES 2023 CAPLYTA SALES GUIDANCE

Nov 2, 2023 20:01

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND RAISES 2023 CAPLYTA SALES GUIDANCE

Aug 3, 2023 19:39

Intra-Cellular Therapies | 8-K: Current report

Jun 24, 2023 04:15

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 4, 2023 19:37

Intra-Cellular Therapies | DEFA14A: Others

Apr 29, 2023 04:42

Intra-Cellular Therapies | DEF 14A: Definitive proxy statements

Apr 29, 2023 04:39

Intra-Cellular Therapies | 8-K: Current report

Mar 28, 2023 19:12

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 1, 2023 20:41

Intra-Cellular Therapies | 8-K: Current report

Jan 10, 2023 06:13

Intra-Cellular Therapies | 8-K: Current report

Dec 23, 2022 05:09